Exelixis Inc reports results for the quarter ended in December - Earnings Summary

Exelixis

06/02/2024 22:53

* Exelixis Inc  EXEL.OQ  reported quarterly adjusted
earnings of
27 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -9 cents.  The mean expectation of nineteen analysts for the
quarter was for earnings of 21 cents per share. Wall Street
expected results to range from 5 cents to 28 cents per share.
    * Revenue rose 13.1% to $479.65 million from a year ago;
analysts
expected $480.17 million. 
    * Exelixis Inc's reported EPS for the quarter was 27 cents​.
    * The company reported quarterly net income of $85.52
million.
    * Exelixis Inc shares had fallen by 10.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.4%
in the last three months.​ 
    * In the last 30 days, eight analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is
$27.00 
This summary was machine generated from LSEG data February 6 at
10:53 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.21           0.27           Beat
 Sep. 30 2023      0.10           0.00           Missed
 Jun. 30 2023      0.16           0.25           Beat
 Mar. 31 2023      0.15           0.12           Missed